P J Olbert1, M Maier, H Heers, A Hegele, R Hofmann. 1. Klinik für Urologie und Kinderurologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Baldingerstraße, 35043, Marburg, Deutschland, peter.olbert@med.uni-marburg.de.
Abstract
BACKGROUND: The indications for nephron-sparing surgery have been considerably extended by guideline recommendations in recent years. It remains unclear whether clinical practice still reflects these new guidelines. OBJECTIVE: In this retrospective, monocentric analysis at a tertiary referral center the indications for partial nephrectomy over a 13-year period were evaluated. METHODS: In a retrospective database analysis all cases of surgically treated renal masses from 2001 to 2013 were evaluated. Besides demographic, tumor-specific and perioperative variables the development of the surgical technique depending on the tumor stage was evaluated. RESULTS AND DISCUSSION: The proportion of nephron-sparing surgery cases increased from below 20 % in 2001 to 35 % in 2013 in the entire cohort. For stage T1a tumors, partial nephrectomy increased from approximately 50 % to over 90 % and for T1b tumors it rose from 10 % to 50 %. Logistic regression revealed stage 1 tumors to be predictive of partial nephrectomy over the complete evaluation period. Extending the indications for partial nephrectomy even to higher stages is under discussion but not yet supported by data from prospective, controlled studies.
BACKGROUND: The indications for nephron-sparing surgery have been considerably extended by guideline recommendations in recent years. It remains unclear whether clinical practice still reflects these new guidelines. OBJECTIVE: In this retrospective, monocentric analysis at a tertiary referral center the indications for partial nephrectomy over a 13-year period were evaluated. METHODS: In a retrospective database analysis all cases of surgically treated renal masses from 2001 to 2013 were evaluated. Besides demographic, tumor-specific and perioperative variables the development of the surgical technique depending on the tumor stage was evaluated. RESULTS AND DISCUSSION: The proportion of nephron-sparing surgery cases increased from below 20 % in 2001 to 35 % in 2013 in the entire cohort. For stage T1a tumors, partial nephrectomy increased from approximately 50 % to over 90 % and for T1b tumors it rose from 10 % to 50 %. Logistic regression revealed stage 1 tumors to be predictive of partial nephrectomy over the complete evaluation period. Extending the indications for partial nephrectomy even to higher stages is under discussion but not yet supported by data from prospective, controlled studies.
Authors: Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester Journal: Eur Urol Date: 2010-12-22 Impact factor: 20.096
Authors: Sandra Waalkes; Frank Becker; Andres J Schrader; Martin Janssen; Gerd Wegener; Axel S Merseburger; Mark Schrader; Rainer Hofmann; Michael Stöckle; Markus A Kuczyk Journal: Eur Urol Date: 2010-10-15 Impact factor: 20.096
Authors: Simon P Kim; Angela L Alt; Christopher J Weight; Brian A Costello; John C Cheville; Christine Lohse; Cristine Allmer; Bradley C Leibovich Journal: J Urol Date: 2011-04-15 Impact factor: 7.450
Authors: Jens Hansen; Maxine Sun; Marco Bianchi; Michael Rink; Zhe Tian; Nawar Hanna; Malek Meskawi; Jan Schmitges; Shahrokh F Shariat; Felix K-H Chun; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz Journal: Urology Date: 2012-06-13 Impact factor: 2.649
Authors: Jens Bedke; Stephan Buse; Maria Pritsch; Stephan Macher-Goeppinger; Peter Schirmacher; Axel Haferkamp; Markus Hohenfellner Journal: BJU Int Date: 2008-12-08 Impact factor: 5.588
Authors: J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray Journal: Eur J Cancer Date: 2013-02-26 Impact factor: 9.162
Authors: Malek Meskawi; Andreas Becker; Marco Bianchi; Quoc-Dien Trinh; Florian Roghmann; Zhe Tian; Markus Graefen; Paul Perrotte; Pierre I Karakiewicz; Maxine Sun Journal: Int J Urol Date: 2013-07-02 Impact factor: 3.369
Authors: Ryan P Kopp; Reza Mehrazin; Kerrin L Palazzi; Michael A Liss; Ramzi Jabaji; Hossein S Mirheydar; Hak J Lee; Nishant Patel; Fuad Elkhoury; Anthony L Patterson; Ithaar H Derweesh Journal: BJU Int Date: 2014-10-03 Impact factor: 5.588
Authors: J J Wendler; B Friebe; D Baumunk; A Blana; T Franiel; R Ganzer; B Hadaschik; T Henkel; K U Köhrmann; J Köllermann; T Kuru; S Machtens; A Roosen; G Salomon; H P Schlemmer; L Sentker; U Witzsch; U B Liehr; J Ricke; M Schostak Journal: Urologe A Date: 2016-05 Impact factor: 0.639